Literature DB >> 18709668

High frequency extradural motor cortex stimulation transiently improves axial symptoms in a patient with Parkinson's disease.

Alfonso Fasano1, Carla Piano, Celestino De Simone, Beatrice Cioni, Daniela Di Giuda, Massimiliano Zinno, Antonio Daniele, Mario Meglio, Alessandro Giordano, Anna Rita Bentivoglio.   

Abstract

In a primate model of Parkinson's disease (PD), the benefit of extradural motor cortex stimulation (EMCS) was associated with high-frequency stimulation (130 Hz), whereas no significant motor improvement was achieved at 10 Hz or intermediate frequencies of stimulation. We report the case of a 72-year-old female patient affected by severe PD who underwent bilateral EMCS. In baseline med-off condition the patient was unable to arise from a chair and to stand without assistance. Stimulation at 3 and 60 Hz failed to provide any improvement of symptoms, whereas, when stimulating at 130 Hz, axial akinesia and walking improved consistently: the patient, in med-off condition, was able to arise from chair and to walk without assistance. The patient underwent two brain 99mTc- Ethylcysteinate Dimer-SPECT studies: semiquantitative and Statistical Parametric Mapping revealed that the regional cerebral perfusion was significantly increased in the supplementary motor area during stimulation at 130 Hz. After five months, the benefit of EMCS gradually disappeared. (c) 2008 Movement Disorder Society.

Entities:  

Mesh:

Year:  2008        PMID: 18709668     DOI: 10.1002/mds.21977

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  14 in total

Review 1.  The neurobiology of falls.

Authors:  Alfonso Fasano; Meir Plotnik; Francesco Bove; Alfredo Berardelli
Journal:  Neurol Sci       Date:  2012-06-05       Impact factor: 3.307

Review 2.  Critical involvement of the motor cortex in the pathophysiology and treatment of Parkinson's disease.

Authors:  David Lindenbach; Christopher Bishop
Journal:  Neurosci Biobehav Rev       Date:  2013-10-07       Impact factor: 8.989

Review 3.  Axial disability and deep brain stimulation in patients with Parkinson disease.

Authors:  Alfonso Fasano; Camila C Aquino; Joachim K Krauss; Christopher R Honey; Bastiaan R Bloem
Journal:  Nat Rev Neurol       Date:  2015-01-13       Impact factor: 42.937

4.  Lesions causing freezing of gait localize to a cerebellar functional network.

Authors:  Alfonso Fasano; Simon E Laganiere; Susy Lam; Michael D Fox
Journal:  Ann Neurol       Date:  2017-01       Impact factor: 10.422

5.  Neurologic aspects and falls.

Authors:  Alfonso Fasano; Meir Plotnik
Journal:  Clin Cases Miner Bone Metab       Date:  2012-05-29

6.  A novel combinational approach of microstimulation and bioluminescence imaging to study the mechanisms of action of cerebral electrical stimulation in mice.

Authors:  Dany Arsenault; Janelle Drouin-Ouellet; Martine Saint-Pierre; Petros Petrou; Marilyn Dubois; Jasna Kriz; Roger A Barker; Antonio Cicchetti; Francesca Cicchetti
Journal:  J Physiol       Date:  2015-03-24       Impact factor: 5.182

Review 7.  Evolving concepts on bradykinesia.

Authors:  Matteo Bologna; Giulia Paparella; Alfonso Fasano; Mark Hallett; Alfredo Berardelli
Journal:  Brain       Date:  2020-03-01       Impact factor: 13.501

Review 8.  Can a Positive Allosteric Modulation of GABAergic Receptors Improve Motor Symptoms in Patients with Parkinson's Disease? The Potential Role of Zolpidem in the Treatment of Parkinson's Disease.

Authors:  Antonio Daniele; Francesco Panza; Antonio Greco; Giancarlo Logroscino; Davide Seripa
Journal:  Parkinsons Dis       Date:  2016-05-17

Review 9.  Neuroimaging of Freezing of Gait.

Authors:  Alfonso Fasano; Talia Herman; Alessandro Tessitore; Antonio P Strafella; Nicolaas I Bohnen
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

Review 10.  Deep Brain Stimulation in Parkinson's Disease: New and Emerging Targets for Refractory Motor and Nonmotor Symptoms.

Authors:  Dustin Anderson; Grayson Beecher; Fang Ba
Journal:  Parkinsons Dis       Date:  2017-07-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.